Robert Carter - 17 Nov 2025 Form 4 Insider Report for Oncology Institute, Inc. (TOI)

Role
Chief Financial Officer
Signature
/s/ Mark Hueppelsheuser, Attorney-in-fact for Robert Carter
Issuer symbol
TOI
Transactions as of
17 Nov 2025
Transactions value $
$0
Form type
4
Filing time
19 Nov 2025, 18:00:18 UTC
Previous filing
22 May 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Carter Robert Ross Chief Financial Officer C/O THE ONCOLOGY INSTITUTE INC., 18000 STUDEBAKER RD #800, CERRITOS /s/ Mark Hueppelsheuser, Attorney-in-fact for Robert Carter 19 Nov 2025 0002039341

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TOI Common Stock Award $0 +195 +0.08% $0.00 235K 17 Nov 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents RSU awards that were fully vested upon grant, net of withholding tax obligations.